Hong Kong To Limit Tests, Antivirals To Those At High H1N1 Flu Risk
This article was originally published in PharmAsia News
Executive Summary
Hong Kong authorities have decided to limit tests and antiviral treatment for the H1N1 flu to patients considered at high risk for the disease. Clinicians are to determine those who should be treated, the Hong Kong Hospital Authority said. The tests and treatment are to be given to patients showing symptoms if they are under six years of age, pregnant or have chronic diseases, or have a persistent fever two days after symptomatic treatment. (Click here for more